뇌졸중 재활 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for stroke rehabilitation. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global stroke rehabilitation market from 2025 to 2032.

Key Insights:

• Stroke Rehabilitation Market Size (2025E): USD 295.5 Mn
• Projected Market Value (2032F): USD 543.7 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 9.1%

Stroke Rehabilitation Market - Report Scope:

Stroke rehabilitation plays a crucial role in helping patients recover lost functions and regain independence after a stroke. The rehabilitation process includes physical therapy, occupational therapy, speech therapy, and neurorehabilitation technologies. The stroke rehabilitation market serves hospitals, rehabilitation centers, outpatient clinics, and homecare settings, offering a range of therapies, devices, and services tailored to individual patient needs. Market growth is driven by the rising prevalence of strokes, increasing geriatric population, and advancements in rehabilitation technology, improving patient outcomes and recovery efficiency.

Market Growth Drivers:

The global stroke rehabilitation market is propelled by several key factors, including the increasing incidence of strokes due to aging populations and lifestyle-related risk factors such as hypertension, diabetes, and obesity. Growing awareness of post-stroke rehabilitation and the importance of early intervention is driving demand for rehabilitation therapies and assistive devices. Technological advancements, such as robotic rehabilitation, virtual reality (VR)-based therapy, and brain-computer interface (BCI) devices, enhance patient engagement and accelerate recovery, further fueling market expansion. Additionally, government initiatives and healthcare reforms promoting stroke care and rehabilitation services contribute to market growth.

Market Restraints:

Despite promising growth prospects, the stroke rehabilitation market faces challenges related to high treatment costs, limited reimbursement policies, and accessibility issues, particularly in low- and middle-income countries. The high cost of advanced rehabilitation devices and therapies limits affordability, creating barriers to widespread adoption. Moreover, a shortage of skilled rehabilitation professionals and regional disparities in healthcare infrastructure impact the availability and effectiveness of rehabilitation services. Addressing these challenges requires policy support, investment in affordable solutions, and enhanced training programs for healthcare professionals.

Market Opportunities:

The stroke rehabilitation market presents significant growth opportunities driven by innovations in digital health, home-based rehabilitation, and AI-powered rehabilitation solutions. The adoption of tele-rehabilitation platforms enables remote therapy sessions, expanding access to rehabilitation services in underserved regions. The integration of artificial intelligence (AI) and machine learning in rehabilitation devices enhances personalized treatment plans and accelerates patient progress. Furthermore, collaborations between healthcare providers, research institutions, and medical device manufacturers foster innovation, leading to new rehabilitation solutions and improved patient outcomes. Expanding rehabilitation programs in emerging markets and promoting public-private partnerships further support market expansion.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the stroke rehabilitation market globally?
• Which therapies and rehabilitation technologies are gaining traction across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the stroke rehabilitation market?
• Who are the key players contributing to the stroke rehabilitation market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global stroke rehabilitation market?

Competitive Intelligence and Business Strategy:

Leading players in the global stroke rehabilitation market, including Medtronic, Bionik Laboratories, Hocoma AG, and Ekso Bionics, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced rehabilitation solutions, including robotic exoskeletons, neuromodulation devices, and AI-driven therapy systems, catering to diverse patient needs. Collaborations with healthcare providers, rehabilitation centers, and academic institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the evolving stroke rehabilitation landscape.

Key Companies Profiled:

• Medtronic
• Bionik Laboratories
• Hocoma AG
• Ekso Bionics
• Bioxtreme Robotics Rehabilitation
• ReWalk Robotics
• Abbott Laboratories
• Neofect
• Tyromotion GmbH
• DJO Global

Stroke Rehabilitation Market Research Segmentation:

By Therapy Type:

• Physical Therapy
• Occupational Therapy
• Speech and Language Therapy
• Cognitive Therapy

By Technology:

• Robotic Rehabilitation Devices
• Neurorehabilitation Devices
• Wearable Devices
• Brain-Computer Interface (BCI) Systems
• Virtual Reality (VR)-Based Rehabilitation

By End-User:

• Hospitals
• Rehabilitation Centers
• Outpatient Clinics
• Homecare Settings

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusion and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Application Innovation / Development Trends

4. Key Success Factors

• 4.1. Stroke Incidence Rates
• 4.2. Technology Roadmap
• 4.3. Regulatory Scenario
• 4.4. Product Adoption Rate
• 4.5. Key Promotional Strategies By Manufacturers
• 4.6. Porter's Analysis
• 4.7. PESTEL Analysis
• 4.8. Value Chain Analysis
• 4.9. List of Capital Devices for the Future of Stroke Rehabilitation

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Outlook
  • 5.1.2. Global Healthcare Spending Outlook
  • 5.1.3. Global Cardiovascular Disease Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. New Product Launches
  • 5.2.2. Product Adoption Rate
  • 5.2.3. Rising Prevalence of Stroke
  • 5.2.4. Advancement in Technology
  • 5.2.5. Rising ageing population
  • 5.2.6. Increased Funding and Support from Government
  • 5.2.7. GDP Growth
  • 5.2.8. COVID 19 Pandemic
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

• 6.1. Current COVID19 Statistics and Probable Future Impact
• 6.2. Current GDP Projection and Probable Impact
• 6.3. COVID19 and Impact Analysis
  • 6.3.1. By Product
  • 6.3.2. By Stroke Type
  • 6.3.3. By End User
• 6.4. 2024 Market Scenario

7. Global Stroke Rehabilitation Market Demand Value (US$ Mn) Analysis 2019 - 2024 and Forecast, 2025 - 2032

• 7.1. Historical Market Value (US$ Mn) Analysis, 2019 - 2024
• 7.2. Current and Future Market Value (US$ Mn) Projections, 2025 - 2032
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Stroke Rehabilitation Market Analysis 2019 - 2032, By Product

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Value (US$ Mn) By Product, 2019 - 2024
• 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product, 2025 - 2032
  • 8.3.1. Electrical Stimulators
    • 8.3.1.1. Table Top
    • 8.3.1.2. Wearable
  • 8.3.2. Robotic Stimulators
  • 8.3.3. Wireless Stimulators
  • 8.3.4. Non-Invasive Stimulators
  • 8.3.5. Cognitive Stimulators
  • 8.3.6. Others
• 8.4. Market Attractiveness Analysis By Product

9. Global Stroke Rehabilitation Market Analysis 2019 - 2032, By Stroke Type

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis By Stroke Type, 2019 - 2024
• 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Stroke Type, 2025 - 2032
  • 9.3.1. Ischemic Stroke
  • 9.3.2. Hemorrhagic Stroke
  • 9.3.3. Transient Ischemic Attack
• 9.4. Attractiveness Analysis By Stroke Type

10. Global Stroke Rehabilitation Market Analysis 2019 - 2032, By End User

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2024
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2025 - 2032
  • 10.3.1. Hospitals
  • 10.3.2. Specialty Clinics
  • 10.3.3. Ambulatory Surgical Centers
  • 10.3.4. Long Term Treatment Centers
  • 10.3.5. Home Care Settings
  • 10.3.6. Rehabilitation Centers
• 10.4. Market Attractiveness Analysis By End User

11. Global Stroke Rehabilitation Market Analysis 2019 - 2032, By Region

• 11.1. Introduction
• 11.2. Historical Market Value (US$ Mn) Analysis By Region, 2019 - 2024
• 11.3. Current Market Value (US$ Mn) Analysis and Forecast By Region, 2025 - 2032
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. East Asia
  • 11.3.5. South Asia
  • 11.3.6. Oceania
  • 11.3.7. Middle East and Africa (MEA)
• 11.4. Market Attractiveness Analysis By Region

12. North America Stroke Rehabilitation Market Analysis 2019 - 2032

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019 - 2024
• 12.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2025 - 2032
  • 12.3.1. By Country
    • 12.3.1.1. U.S.
    • 12.3.1.2. Canada
  • 12.3.2. By Product
  • 12.3.3. By Stroke Type
  • 12.3.4. By End User
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Product
  • 12.4.3. By Stroke Type
  • 12.4.4. By End User
• 12.5. Market Trends
• 12.6. Key Market Participants - Intensity Mapping
• 12.7. Drivers and Restraints - Impact Analysis
• 12.8. Country Level Analysis & Forecast
  • 12.8.1. U.S. Stroke Rehabilitation Market
    • 12.8.1.1. Introduction
    • 12.8.1.2. Market Analysis and Forecast By Market Taxonomy
      • 12.8.1.2.1. By Product
      • 12.8.1.2.2. By Stroke Type
      • 12.8.1.2.3. By End User
  • 12.8.2. Canada Stroke Rehabilitation Market
    • 12.8.2.1. Introduction
    • 12.8.2.2. Market Analysis and Forecast By Market Taxonomy
      • 12.8.2.2.1. By Product
      • 12.8.2.2.2. By Stroke Type
      • 12.8.2.2.3. By End User

13. Latin America Stroke Rehabilitation Market Analysis 2019 - 2032

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019 - 2024
• 13.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2025 - 2032
  • 13.3.1. By Country
    • 13.3.1.1. Brazil
    • 13.3.1.2. Mexico
    • 13.3.1.3. Argentina
    • 13.3.1.4. Rest of Latin America
  • 13.3.2. By Product
  • 13.3.3. By Stroke Type
  • 13.3.4. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By Stroke Type
  • 13.4.4. By End User
• 13.5. Market Trends
• 13.6. Key Market Participants - Intensity Mapping
• 13.7. Drivers and Restraints - Impact Analysis
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. Brazil Stroke Rehabilitation Market
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast By Market Taxonomy
      • 13.8.1.2.1. By Product
      • 13.8.1.2.2. By Stroke Type
      • 13.8.1.2.3. By End User
  • 13.8.2. Mexico Stroke Rehabilitation Market
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast By Market Taxonomy
      • 13.8.2.2.1. By Product
      • 13.8.2.2.2. By Stroke Type
      • 13.8.2.2.3. By End User
  • 13.8.3. Argentina Stroke Rehabilitation Market
    • 13.8.3.1. Introduction
    • 13.8.3.2. Market Analysis and Forecast By Market Taxonomy
      • 13.8.3.2.1. By Product
      • 13.8.3.2.2. By Stroke Type
      • 13.8.3.2.3. By End User

14. Europe Stroke Rehabilitation Market Analysis 2019 - 2032

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019 - 2024
• 14.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2025 - 2032
  • 14.3.1. By Country
    • 14.3.1.1. Germany
    • 14.3.1.2. Italy
    • 14.3.1.3. France
    • 14.3.1.4. U.K.
    • 14.3.1.5. Spain
    • 14.3.1.6. BENELUX
    • 14.3.1.7. Russia
    • 14.3.1.8. Switzerland
    • 14.3.1.9. Nordic Countries
    • 14.3.1.10. Rest of Europe
  • 14.3.2. By Product
  • 14.3.3. By Stroke Type
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Stroke Type
  • 14.4.4. By End User
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. Germany Stroke Rehabilitation Market
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast By Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Stroke Type
      • 14.8.1.2.3. By End User
  • 14.8.2. Italy Stroke Rehabilitation Market
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast By Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Stroke Type
      • 14.8.2.2.3. By End User
  • 14.8.3. France Stroke Rehabilitation Market
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast By Market Taxonomy
      • 14.8.3.2.1. By Product
      • 14.8.3.2.2. By Stroke Type
      • 14.8.3.2.3. By End User
  • 14.8.4. U.K. Stroke Rehabilitation Market
    • 14.8.4.1. Introduction
    • 14.8.4.2. Market Analysis and Forecast By Market Taxonomy
      • 14.8.4.2.1. By Product
      • 14.8.4.2.2. By Stroke Type
      • 14.8.4.2.3. By End User
  • 14.8.5. Spain Stroke Rehabilitation Market
    • 14.8.5.1. Introduction
    • 14.8.5.2. Market Analysis and Forecast By Market Taxonomy
      • 14.8.5.2.1. By Product
      • 14.8.5.2.2. By Stroke Type
      • 14.8.5.2.3. By End User
  • 14.8.6. BENELUX Union Stroke Rehabilitation Market
    • 14.8.6.1. Introduction
    • 14.8.6.2. Market Analysis and Forecast By Market Taxonomy
      • 14.8.6.2.1. By Product
      • 14.8.6.2.2. By Stroke Type
      • 14.8.6.2.3. By End User
  • 14.8.7. Nordic Countries Stroke Rehabilitation Market
    • 14.8.7.1. Introduction
    • 14.8.7.2. Market Analysis and Forecast By Market Taxonomy
      • 14.8.7.2.1. By Product
      • 14.8.7.2.2. By Stroke Type
      • 14.8.7.2.3. By End User
  • 14.8.8. Russia Stroke Rehabilitation Market
    • 14.8.8.1. Introduction
    • 14.8.8.2. Market Analysis and Forecast By Market Taxonomy
      • 14.8.8.2.1. By Product
      • 14.8.8.2.2. By Stroke Type
      • 14.8.8.2.3. By End User
  • 14.8.9. Switzerland Stroke Rehabilitation Market
    • 14.8.9.1. Introduction
    • 14.8.9.2. Market Analysis and Forecast By Market Taxonomy
      • 14.8.9.2.1. By Product
      • 14.8.9.2.2. By Stroke Type
      • 14.8.9.2.3. By End User

15. South Asia Stroke Rehabilitation Market Analysis 2019 - 2032

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019 - 2024
• 15.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2025 - 2032
  • 15.3.1. By Country
    • 15.3.1.1. India
    • 15.3.1.2. Thailand
    • 15.3.1.3. Indonesia
    • 15.3.1.4. Malaysia
    • 15.3.1.5. Philippines
    • 15.3.1.6. Rest of South Asia
  • 15.3.2. By Product
  • 15.3.3. By Stroke Type
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Stroke Type
  • 15.4.4. By End User
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. India Stroke Rehabilitation Market
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast By Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Stroke Type
      • 15.8.1.2.3. By End User
  • 15.8.2. Indonesia Stroke Rehabilitation Market
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast By Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Stroke Type
      • 15.8.2.2.3. By End User
  • 15.8.3. Malaysia Stroke Rehabilitation Market
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast By Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Stroke Type
      • 15.8.3.2.3. By End User
  • 15.8.4. Thailand Stroke Rehabilitation Market
    • 15.8.4.1. Introduction
    • 15.8.4.2. Market Analysis and Forecast By Market Taxonomy
      • 15.8.4.2.1. By Product
      • 15.8.4.2.2. By Stroke Type
      • 15.8.4.2.3. By End User
  • 15.8.5. Philippines Stroke Rehabilitation Market
    • 15.8.5.1. Introduction
    • 15.8.5.2. Market Analysis and Forecast By Market Taxonomy
      • 15.8.5.2.1. By Product
      • 15.8.5.2.2. By Stroke Type
      • 15.8.5.2.3. By End User

16. East Asia Stroke Rehabilitation Market Analysis 2019 - 2032

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019 - 2024
• 16.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2025 - 2032
  • 16.3.1. By Country
    • 16.3.1.1. China
    • 16.3.1.2. Japan
    • 16.3.1.3. South Korea
  • 16.3.2. By Product
  • 16.3.3. By Stroke Type
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Stroke Type
  • 16.4.4. By End User
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. China Stroke Rehabilitation Market
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast By Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Stroke Type
      • 16.8.1.2.3. By End User
  • 16.8.2. Japan Stroke Rehabilitation Market
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast By Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Stroke Type
      • 16.8.2.2.3. By End User
  • 16.8.3. South Korea Stroke Rehabilitation Market
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast By Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Stroke Type
      • 16.8.3.2.3. By End User

17. Oceania Stroke Rehabilitation Market Analysis 2019 - 2032

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019 - 2024
• 17.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2025 - 2032
  • 17.3.1. By Country
    • 17.3.1.1. Australia
    • 17.3.1.2. New Zealand
  • 17.3.2. By Product
  • 17.3.3. By Stroke Type
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Stroke Type
  • 17.4.4. By End User
• 17.5. Market Trends
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. Australia Stroke Rehabilitation Market
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast By Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Stroke Type
      • 17.8.1.2.3. By End User
  • 17.8.2. New Zealand Stroke Rehabilitation Market
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast By Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Stroke Type
      • 17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Stroke Rehabilitation Market Analysis 2019 - 2032

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019 - 2024
• 18.3. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2025 - 2032
  • 18.3.1. By Country
    • 18.3.1.1. GCC Countries
    • 18.3.1.2. Israel
    • 18.3.1.3. Turkey
    • 18.3.1.4. North Africa
    • 18.3.1.5. South Africa
    • 18.3.1.6. Egypt
    • 18.3.1.7. Rest of Middle East and Africa
  • 18.3.2. By Product
  • 18.3.3. By Stroke Type
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Stroke Type
  • 18.4.4. By End User
• 18.5. Market Trends
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. GCC Countries Stroke Rehabilitation Market
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast By Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Stroke Type
      • 18.8.1.2.3. By End User
  • 18.8.2. Israel Stroke Rehabilitation Market
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast By Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Stroke Type
      • 18.8.2.2.3. By End User
  • 18.8.3. Turkey Stroke Rehabilitation Market
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast By Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By Stroke Type
      • 18.8.3.2.3. By End User
  • 18.8.4. South Africa Stroke Rehabilitation Market
    • 18.8.4.1. Introduction
    • 18.8.4.2. Market Analysis and Forecast By Market Taxonomy
      • 18.8.4.2.1. By Product
      • 18.8.4.2.2. By Stroke Type
      • 18.8.4.2.3. By End User
  • 18.8.5. North Africa Stroke Rehabilitation Market
    • 18.8.5.1. Introduction
    • 18.8.5.2. Market Analysis and Forecast By Market Taxonomy
      • 18.8.5.2.1. By Product
      • 18.8.5.2.2. By Stroke Type
      • 18.8.5.2.3. By End User
  • 18.8.6. Egypt Stroke Rehabilitation Market
    • 18.8.6.1. Introduction
    • 18.8.6.2. Market Analysis and Forecast By Market Taxonomy
      • 18.8.6.2.1. By Product
      • 18.8.6.2.2. By Stroke Type
      • 18.8.6.2.3. By End User

19. Market Structure Analysis

• 19.1. Market Analysis By Tier of Companies
• 19.2. Market Share Analysis of Top Players
• 19.3. Market Presence Analysis
  • 19.3.1. Regional footprint of Players
  • 19.3.2. Channel Foot Print By Players

20. Competition Deep Dive

• 20.1. Competition Dashboard
• 20.2. Technology Foot-Print, By Competition
• 20.3. Competition Benchmarking
• 20.4. Competition Deep Dive
  • 20.4.1. Penumbra, Inc. (REAL System)
    • 20.4.1.1. Overview
    • 20.4.1.2. Service Portfolio
    • 20.4.1.3. Key Financials
    • 20.4.1.4. Strategy Overview
    • 20.4.1.5. SWOT Analysis
  • 20.4.2. Saebo Inc
    • 20.4.2.1. Overview
    • 20.4.2.2. Service Portfolio
    • 20.4.2.3. Key Financials
    • 20.4.2.4. Strategy Overview
    • 20.4.2.5. SWOT Analysis
  • 20.4.3. Shanghai Siyi Intelligent Technology Co., Ltd.
    • 20.4.3.1. Overview
    • 20.4.3.2. Service Portfolio
    • 20.4.3.3. Key Financials
    • 20.4.3.4. Strategy Overview
    • 20.4.3.5. SWOT Analysis
  • 20.4.4. DJO Global
    • 20.4.4.1. Overview
    • 20.4.4.2. Service Portfolio
    • 20.4.4.3. Key Financials
    • 20.4.4.4. Strategy Overview
    • 20.4.4.5. SWOT Analysis
  • 20.4.5. Shenzhen XFT Medical
    • 20.4.5.1. Overview
    • 20.4.5.2. Service Portfolio
    • 20.4.5.3. Key Financials
    • 20.4.5.4. Strategy Overview
    • 20.4.5.5. SWOT Analysis
  • 20.4.6. Soterix Medical Inc.
    • 20.4.6.1. Overview
    • 20.4.6.2. Service Portfolio
    • 20.4.6.3. Key Financials
    • 20.4.6.4. Strategy Overview
    • 20.4.6.5. SWOT Analysis
  • 20.4.7. Restorative Therapies
    • 20.4.7.1. Overview
    • 20.4.7.2. Service Portfolio
    • 20.4.7.3. Key Financials
    • 20.4.7.4. Strategy Overview
    • 20.4.7.5. SWOT Analysis
  • 20.4.8. Zynex Medical, Inc
    • 20.4.8.1. Overview
    • 20.4.8.2. Service Portfolio
    • 20.4.8.3. Key Financials
    • 20.4.8.4. Strategy Overview
    • 20.4.8.5. SWOT Analysis
  • 20.4.9. MYOLYN
    • 20.4.9.1. Overview
    • 20.4.9.2. Service Portfolio
    • 20.4.9.3. Key Financials
    • 20.4.9.4. Strategy Overview
    • 20.4.9.5. SWOT Analysis
  • 20.4.10. ACP - Accelerated Care Plus.
    • 20.4.10.1. Overview
    • 20.4.10.2. Service Portfolio
    • 20.4.10.3. Key Financials
    • 20.4.10.4. Strategy Overview
    • 20.4.10.5. SWOT Analysis
  • 20.4.11. Neurosoft
    • 20.4.11.1. Overview
    • 20.4.11.2. Service Portfolio
    • 20.4.11.3. Key Financials
    • 20.4.11.4. Strategy Overview
    • 20.4.11.5. SWOT Analysis
  • 20.4.12. BIONIK Inc.
    • 20.4.12.1. Overview
    • 20.4.12.2. Service Portfolio
    • 20.4.12.3. Key Financials
    • 20.4.12.4. Strategy Overview
    • 20.4.12.5. SWOT Analysis
  • 20.4.13. EB Neuro S.p.A.
    • 20.4.13.1. Overview
    • 20.4.13.2. Service Portfolio
    • 20.4.13.3. Key Financials
    • 20.4.13.4. Strategy Overview
    • 20.4.13.5. SWOT Analysis
  • 20.4.14. Motorika Medical
    • 20.4.14.1. Overview
    • 20.4.14.2. Service Portfolio
    • 20.4.14.3. Key Financials
    • 20.4.14.4. Strategy Overview
    • 20.4.14.5. SWOT Analysis
  • 20.4.15. Ottobock
    • 20.4.15.1. Overview
    • 20.4.15.2. Service Portfolio
    • 20.4.15.3. Key Financials
    • 20.4.15.4. Strategy Overview
    • 20.4.15.5. SWOT Analysis
  • 20.4.16. Guangzhou Longest Science & Technology Co., Ltd.
    • 20.4.16.1. Overview
    • 20.4.16.2. Service Portfolio
    • 20.4.16.3. Key Financials
    • 20.4.16.4. Strategy Overview
    • 20.4.16.5. SWOT Analysis
  • 20.4.17. Roceso Technologies Pte Ltd
    • 20.4.17.1. Overview
    • 20.4.17.2. Service Portfolio
    • 20.4.17.3. Key Financials
    • 20.4.17.4. Strategy Overview
    • 20.4.17.5. SWOT Analysis
  • 20.4.18. Brain Stimulation AB
    • 20.4.18.1. Overview
    • 20.4.18.2. Service Portfolio
    • 20.4.18.3. Key Financials
    • 20.4.18.4. Strategy Overview
    • 20.4.18.5. SWOT Analysis

21. Assumptions and Acronyms Used

22. Research Methodology